Skip to main content
HURN
NASDAQ Trade & Services

Broad-Based Demand Lifts Huron Q2 Revenue 16%, EPS Surges 75% as Margins Expand

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$121.37
Mkt Cap
$1.968B
52W Low
$84.875
52W High
$186.775
52W Position info
43% above low
Off High info
35% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

HURN sits 43% above its 52-week low of $84.875.

Summary

Huron Consulting posted Q2 2026 revenue of $465.6M (up 15.7% YoY) and diluted EPS of $1.91 (up 75.2%), driven by broad-based demand and margin improvement. The company repurchased $53.1M in shares and closed the RelateCare acquisition.


Key Events · Earnings and Guidance · HURN

  • Revenue Growth Accelerates

    Revenues before reimbursable expenses (RBR) rose 15.7% to $465.6M, with Healthcare up 17.4%, Education up 7.8%, and Commercial up 24.6%. Organic growth was 10.8% excluding acquisitions.

  • Earnings Surge

    Net income jumped 60.8% to $31.2M, and diluted EPS increased 75.2% to $1.91. Adjusted diluted EPS rose 30.2% to $2.46, reflecting strong operating leverage.

  • Margin Expansion

    Adjusted EBITDA margin improved to 15.6% from 15.1% a year ago, driven by higher utilization rates (Consulting 81.3%, Digital 81.8%) and operating efficiency.

  • Aggressive Share Repurchases

    The company repurchased 438,456 shares for $53.1M in Q2, reducing diluted share count by 7.8% YoY. $92.0M remains under the $900M authorization.


Analysis · HURN · Trade & Services

A standout quarter for Huron saw revenue before reimbursable expenses climb 15.7% to $465.6 million, fueled by double-digit growth across all three segments. Net income surged 60.8% to $31.2 million, while the adjusted EBITDA margin expanded to 15.6%. Aggressive share repurchases totaling $53.1 million reduced the share count, amplifying EPS growth. Despite higher debt from the RelateCare acquisition and buybacks, the balance sheet remains well-managed with leverage at a comfortable 2.82x. These results confirm strong execution and sustained demand momentum, particularly in Healthcare and Commercial consulting.

At the time of this filing, HURN was trading at $121.37 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $84.88 to $186.78. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HURN - Latest Insights

HURN
Jun 22, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $90.48
Real-time Price: $121.37 info
Change: +$30.89 (+34%) info
Market Cap: $1.968B info
HURN
Jun 03, 2026, 9:39 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $103.87
Real-time Price: $121.37 info
Change: +$17.50 (+17%) info
Market Cap: $1.968B info
HURN
May 05, 2026, 5:28 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $132.22
Real-time Price: $121.37 info
Change: -$10.85 (-8%) info
Market Cap: $1.968B info
HURN
May 05, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $132.22
Real-time Price: $121.37 info
Change: -$10.85 (-8%) info
Market Cap: $1.968B info
HURN
May 05, 2026, 4:19 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $132.22
Real-time Price: $121.37 info
Change: -$10.85 (-8%) info
Market Cap: $1.968B info